Trial NCT03463460

View at ClinicalTrials.gov 
Org. Study IDs: OSU-17234
Secondary IDs: NCI-2018-00192

Last trial update was posted on 2024-03-15

MeSH Interventions

Pembrolizumab Sunitinib

MeSH Conditions

Carcinoma Thymoma

Other Conditions

Thymic Carcinoma

Stopping Reasons

PI decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID